In support of this model, we show clinically that the treatment of peanut allergy with OIT is associated with a decrease in CD209+ DCs, consistent with the idea that disrupting this positive feedback loop impairs the allergic immune response. The gene discussed is CD209; the disease is peanut allergic reaction.